{
  "docId": "019de075-1718-756f-8ae4-37f1cf0d16ed",
  "docSlug": "2a95ead0d9ef429fb8fb8c2cc4a7d704",
  "documentTitle": "AstraZeneca | Investor Event Presentation Deck | 52 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 52,
  "pageCount": 52,
  "prevPage": 51,
  "nextPage": null,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 26,
  "notes": "The slide uses bar charts to compare clinical trial data against historical SoC benchmarks. Right chart excludes pancreatic cohort due to small sample size.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-1718-756f-8ae4-37f1cf0d16ed/52",
  "deckHref": "/decks/019de075-1718-756f-8ae4-37f1cf0d16ed",
  "deckJsonHref": "/decks/019de075-1718-756f-8ae4-37f1cf0d16ed.json",
  "deckAnchorHref": "/decks/019de075-1718-756f-8ae4-37f1cf0d16ed#slide-52",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.44,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "chart",
      "text": "DPT02 Confirmed ORR All Patients vs 2L SoC",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3760a16d-21a9-4bd1-9ac8-b4c350017419",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.44,
        "x": 0.52,
        "y": 0.23
      },
      "kind": "chart",
      "text": "DPT02 Confirmed ORR by IHC status vs 2L SoC",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "877ac91b-5050-4693-88aa-a20fcb05eebc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.03,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "Note: right graph does not show pancreatic cohort data due to small n (1 patient in IHC 2+ subgroup with response). Illustrative data only – cross trial comparisons should always be interpreted with caution",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ff0eb86-87d3-4be0-b6c0-0cb21c5bd7f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. Makker V et al. N Engl J Med. 2022;386(5):437-448; 2. Oaknin A et al. J Immunother Cancer. 2022;10(1):e003777; 3. Pujade-Lauraine E et al. J Clin Oncol. 2014;32(13):1302-1308; 4. Rosenberg JE et al. J Clin Oncol. 2019;37(29):2592-2600; 5. Lamarca A et al. Lancet Oncol. 2021;22(5):690-701; 6. Mita N et al. J Clin Med. 2019;8(6):761. Published 2019 May 29. ORR = objective response rate; SoC = standard of care; 2L = 2nd-line; DPT02 = DestinyPantumor02; IHC = immunohistochemistry",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d989de8-0612-408e-8d6e-8a6154bee06a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.7,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Clinically meaningful responses in DESTINY-Pantumor02 vs 2L SoC in nearly all cohorts",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ec7f766-7b6b-453c-b6bf-5469848e993b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Confirmed ORR in efficacy subset: SoC comparison",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f9570a19-ac9b-42c8-82fe-a8ca6ff3a535",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 52,
      "from": 26,
      "beatId": "a55635e0-23e3-4936-80d1-f995ad7f0061",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The deck concludes with a roadmap for future growth, potential new options for patients, and a summary of key messages",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}